Guangzhou Ruoyuchen TechnologyLtd Valuation
Is 003010 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 003010 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 003010 (CN¥17.28) is trading below our estimate of fair value (CN¥19.29)
Significantly Below Fair Value: 003010 is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 003010?
Other financial metrics that can be useful for relative valuation.
What is 003010's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | n/a |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.5x |
Enterprise Value/EBITDA | 29.4x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does 003010's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 41.9x | ||
002264 New Huadu Technology | 18.4x | 27.1% | CN¥4.3b |
600361 Innovation New Material Technology | 17.5x | 26.5% | CN¥18.0b |
300937 Sichuan Hezong Medicine Easy-to-buy Pharmaceutical | 113.4x | n/a | CN¥2.6b |
600833 Shanghai No.1 PharmacyLtd | 18.3x | n/a | CN¥3.3b |
003010 Guangzhou Ruoyuchen TechnologyLtd | 35.6x | n/a | CN¥2.8b |
Price-To-Earnings vs Peers: 003010 is good value based on its Price-To-Earnings Ratio (35.6x) compared to the peer average (41.9x).
Price to Earnings Ratio vs Industry
How does 003010's PE Ratio compare vs other companies in the CN Consumer Retailing Industry?
Price-To-Earnings vs Industry: 003010 is expensive based on its Price-To-Earnings Ratio (35.6x) compared to the CN Consumer Retailing industry average (25.4x).
Price to Earnings Ratio vs Fair Ratio
What is 003010's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 35.6x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 003010's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.